* denotes 2023 Innovation Award Winner
A dissolving, sharps-free microneedle intradermal injection platform for site specific nonopioid pain relief
A single use, self-administered, dissolving microneedle array for site specific pain relief without the need of a healthcare professional. The sharps-free microneedle array provides rapid intradermal delivery without pain, bleeding, or bruising. A modified version is currently used by CDC, NIH, and UNICEF for vaccines in developing countries.Development of the Gold Nanocontructs for Infection Remediation (AuNIR)
Our technology is known as AuNIR (Gold Nanoconstructs for Infection Remediation). It is an innovative nanotechnological approach that employs an antibody-conjugated, antibiotic-loaded, gold nanocage (AuNC) solution to target MDR pathogens. This multimodal therapeutic intervention takes advantage of the synergistic effects of photodynamic therapy(PDT), photothermal therapy(PTT), and pharmacological intervention.